Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2017 | 06-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 0 | 2,903,139 | 0 | 3,076,220 | 3,141,094 |
| Cost of Goods | 0 | 713,448 | 0 | 732,060 | 664,625 |
| Gross Profit | 0 | 2,189,691 | 0 | 2,344,160 | 2,476,469 |
| Operating Expenses | 0 | 1,798,378 | 0 | 1,715,060 | 1,613,431 |
| Operating Income | 0 | 391,761 | 0 | 629,160 | 863,654 |
| Interest Expense | 0 | 2,529 | 0 | 7,840 | 8,361 |
| Other Income | 0 | 47,007 | 0 | 11,760 | 11,318 |
| Pre-tax Income | 0 | 436,239 | 0 | 633,080 | 866,611 |
| Income Tax | 0 | 54,027 | 0 | 157,780 | 247,120 |
| Net Income Continuous | 0 | 382,212 | 0 | 475,300 | 619,492 |
| Net Income | $0 | $382,212 | $0 | $475,300 | $619,501 |
| EPS Basic Total Ops | N/A | 0.19 | N/A | 0.22 | 0.29 |
| EPS Basic Continuous Ops | N/A | 0.19 | N/A | 0.22 | 0.29 |
| EPS Diluted Total Ops | N/A | 0.19 | N/A | 0.22 | 0.29 |
| EPS Diluted Continuous Ops | N/A | 0.19 | N/A | 0.22 | 0.29 |
| EBITDA(a) | $0 | $535,725 | $0 | $789,251 | $1,012,184 |